Articles

A study by David H. Howard, PhD, Associate Professor, Department of Health Policy and Management, Emory University, Atlanta, and colleagues demonstrated that although anticancer drugs are associated with increased expenses, they were also accompanied by considerable survival benefits across different cancer types (Howard DH, et al. Health Aff [Millwood]. 2016;35:1581-1587)

Immunotherapies Changing the Treatment Landscape of Advanced Cancer Care

By Chase Doyle

Immunotherapy, Personalized Medicine

October 2016, Vol 7, No 9

Precision Medicine Initiative Cohort Program Ushers in a New Era in Medicine

By Jessica Miller

Personalized Medicine

October 2016, Vol 7, No 9

Number of Cancers Convincingly Linked to Obesity More Than Doubles

By Charles Bankhead

Cancer Prevention, Personalized Medicine

October 2016, Vol 7, No 9

Patient Relationship Management: Novel Software for a New Era of Patient Navigation in Oncology

Patient Navigation, Policies & Guidelines

October 2016, Vol 7, No 9

As cancer care providers well know, the landscape of healthcare delivery is changing in complex and dramatic ways. Two related trends are driving this change: the shift among payers to value-based reimbursement, and rapidly evolving patient expectations.

Immunotherapy Moving into Prime Time

By Nick Bryant

Immunotherapy, Personalized Medicine

October 2016, Vol 7, No 9

Molecular Subtypes Predict Response to Radiation in Prostate Cancer

By Phoebe Starr

ASTRO Meeting Highlights

October 2016, Vol 7, No 9